These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3629586)

  • 1. The hematologic effects of cefonicid and cefazedone in the dog: a potential model of cephalosporin hematotoxicity in man.
    Bloom JC; Lewis HB; Sellers TS; Deldar A
    Toxicol Appl Pharmacol; 1987 Aug; 90(1):135-42. PubMed ID: 3629586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hematopathology of cefonicid- and cefazedone-induced blood dyscrasias in the dog.
    Bloom JC; Lewis HB; Sellers TS; Deldar A; Morgan DG
    Toxicol Appl Pharmacol; 1987 Aug; 90(1):143-55. PubMed ID: 3629587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cephalosporin-induced immune cytopenia in the dog: demonstration of erythrocyte-, neutrophil-, and platelet-associated IgG following treatment with cefazedone.
    Bloom JC; Thiem PA; Sellers TS; Deldar A; Lewis HB
    Am J Hematol; 1988 Jun; 28(2):71-8. PubMed ID: 3394717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cephalosporin-induced changes in the ultrastructure of canine bone marrow.
    Deldar A; Lewis H; Bloom J; Weiss L
    Vet Pathol; 1988 May; 25(3):211-8. PubMed ID: 3394212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cephalosporins on fascial healing after celiotomy.
    Scher KS; Scott-Conner CE; Montany PF
    Am J Surg; 1988 Feb; 155(2):361-5. PubMed ID: 3341562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of cefonicid, a long-acting cephalosporin.
    Dudley MN; Quintiliani R; Nightingale CH
    Clin Pharm; 1984; 3(1):23-32. PubMed ID: 6365414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefonicid, a long acting cephalosporin: in vitro activity compared with three cephalosporins and gentamicin.
    Hamilton-Miller JM; Patel R; Brumfitt W
    Drugs Exp Clin Res; 1986; 12(11):861-9. PubMed ID: 3816503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cephalosporin-induced alterations in erythroid (CFU-E) and granulocyte-macrophage (CFU-GM) colony-forming capacity in canine bone marrow.
    Deldar A; Lewis H; Bloom J; Weiss L
    Fundam Appl Toxicol; 1988 Oct; 11(3):450-63. PubMed ID: 3220216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Saltiel E; Brogden RN
    Drugs; 1986 Sep; 32(3):222-59. PubMed ID: 3530703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicologic evaluation of cefamandole nafate in laboratory animals.
    Wold JS; Welles JS; Owen NV; Gibson WR; Morton DM
    J Infect Dis; 1978 May; 137 Suppl():S51-S59. PubMed ID: 650004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose cefazolin versus cefonicid for antibiotic prophylaxis in cesarean delivery.
    Duff P; Robertson AW; Read JA
    Obstet Gynecol; 1987 Nov; 70(5):718-21. PubMed ID: 3658278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial prophylaxis for arthroplasty: a comparative study of cefonicid and cefazolin.
    Davis WA; Kane JG
    Orthopedics; 1987 Oct; 10(10):1405-9. PubMed ID: 3317328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cefonicid and other cephalosporin antibiotics on male sexual development in rats.
    Manson JM; Zolna LE; Kang YJ; Johnson CM
    Antimicrob Agents Chemother; 1987 Jul; 31(7):991-7. PubMed ID: 3662478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative penetration of cefonicid and cefazolin into the atrial appendage and pericardial fluid of patients undergoing open-heart surgery.
    Dudley MN; Nightingale CH; Drezner AD; Low HB; Quintiliani R
    Antimicrob Agents Chemother; 1984 Sep; 26(3):347-50. PubMed ID: 6334490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefonicid kinetics in subjects with normal and impaired renal function.
    Blair AD; Maxwell BM; Forland SC; Jacob L; Cutler RE
    Clin Pharmacol Ther; 1984 Jun; 35(6):798-803. PubMed ID: 6734031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of cefonicid with other beta-lactams regarding the effect of human and mouse sera on antibacterial activity.
    Uri JV
    Acta Microbiol Hung; 1987; 34(1):39-44. PubMed ID: 3630630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of cefonicid in the treatment of staphylococcal infections.
    Lentnek AL; Evrard HM; Wikler MA; Sohn CA; Phillips SW
    Clin Ther; 1985; 7(6):725-32. PubMed ID: 4075363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of disulfiram-type reactions to single and multiple doses of cefonicid: a placebo-controlled study.
    McMahon FG; Ryan JR; Jain AK; LaCorte W; Ginzler F
    J Antimicrob Chemother; 1987 Dec; 20(6):913-8. PubMed ID: 3440774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefonicid vs. cefoxitin for cesarean section prophylaxis.
    Hartert RA; Benrubi G; Thompson RJ; Nuss RC
    J Reprod Med; 1987 Dec; 32(12):907-10. PubMed ID: 3430499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic disposition of cefonicid in patients with renal failure and receiving hemodialysis.
    Barriere SL; Gambertoglio JG; Alexander DP; Stagg RJ; Conte JE
    Rev Infect Dis; 1984; 6 Suppl 4():S809-15. PubMed ID: 6522922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.